Skip to content

Shenqi paste improved muscle measures in selected older adults with diabetic sarcopenia

A placebo-controlled trial reported gains in muscle measures. Changes in fasting insulin, glycated hemoglobin and an insulin resistance index did not differ significantly between groups.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Among older adults with diabetic sarcopenia and a specified traditional medicine syndrome, Shenqi paste improved muscle mass index, grip strength and chair-rise performance compared with placebo. Metabolic results varied by measure. No serious adverse events were reported, but the abstract does not establish long-term safety or applicability to everyone with diabetes.

Keep in mind

The abstract reports statistical significance without quantifying muscle improvements. Its selected clinical subgroup and brief follow-up limit conclusions about broader applicability, the practical importance of the changes and lasting benefit.

THE RESULT, WITH CONTEXT

What researchers found

Greater improvement

Handgrip strength

Shenqi paste versus placebo after 12 weeks; the difference was statistically significant, but its size was not reported.

J Ethnopharmacol, 2026 · Original source ↓

What the trial measured

The main outcomes covered muscle mass index, handgrip strength and time taken to repeatedly rise from a chair. All favored the paste, but the abstract does not quantify how large those differences were.

Metabolic findings were mixed

Fasting blood glucose decreased more with the paste. Changes in fasting insulin, glycated hemoglobin and an insulin resistance index did not differ significantly between groups; this does not show that either group's values stayed unchanged.

CHECK THE ORIGINAL

The original publication

Efficacy and safety of medicine-food homology Shenqi paste in older adults with diabetic sarcopenia: A randomized, double-blind, placebo-controlled trial.

Hua L, Wang Y, Yuan X et al.
J Ethnopharmacol · 2026

PubMed ID
41763617
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.